Outlook Therapeutics said on Wednesday the U.S. health regulator has declined to approve its drug for a type of eye disease, ...

The Pooled Cohort Equations (PCE) cardiovascular risk score stratifies risk for multiple ocular diseases, according to a ...

Thyroid eye disease (TED), also known as Graves’ eye disease or Graves’ ophthalmopathy, is an inflammatory condition in people with thyroid disease. Treatment may include medication, eye drops, and ...

The FDA granted priority review to veligrotug for the treatment of thyroid eye disease, according to a press release from ...

Diabetes, a condition in which the body doesn’t readily produce or utilize insulin to control blood glucose levels, can ...

Thyroid eye disease (TED) is an inflammatory condition affecting those with thyroid disease. There is no cure, but effective management strategies exist. Thyroid eye disease, or Graves’ ophthalmopathy ...

Refractory dry eye in patients with systemic comorbidities can be challenging to manage because the underlying condition or ...

As people age, their eyes change, making it important to stay informed about eye health. Lifestyle choices like wearing ...

Dry eye disease (DED) is one of the most common ocular surface disorders. All DED involves an imbalance between tear production and evaporation. Most cases of DED are driven by excessive evaporation, ...

NASHVILLE, Tenn.--(BUSINESS WIRE)--Harrow (Nasdaq: HROW), a leading U.S. eyecare pharmaceutical company, today announced that VEVYE® (cyclosporine ophthalmic solution) 0.1%, a patented, non‑preserved, ...

Graves’ disease is an autoimmune disorder that primarily affects the thyroid gland. Approximately 27 percent of patients with Graves’ disease in North America will develop an eye disease that is known ...

Doses of Tepezza are given by an intravenous infusion through a blood vessel in your arm. This infusion is usually given at a hospital, health care provider’s office, or infusion center. Sometimes you ...